Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

InterMune's Actimmune enters phase II for treatment of cystic fibrosis

March 2, 2001

EpiGenesis enters agreement with Taisho; receives milestone payment from Chiesi

March 2, 2001

Chiesi regains European marketing rights to Curosurf

Feb. 28, 2001

New muscarinic M3 receptor antagonists and therapeutic uses thereof

Feb. 28, 2001

Beneficial effects of MEN-11467 on tachykininergic mucus secretion seen in ferret trachea

Feb. 28, 2001

Early March launch for new antiallergic agent from Kyowa Hakko

Feb. 27, 2001

Synthesis and use of new chemokine receptor modulators described by AstraZeneca

Feb. 26, 2001

DCEBIO: a new benzimidazolone chloride secretion activator

Feb. 26, 2001

Magainin receives patent for IL-9 antibody for treatment of asthma

Feb. 26, 2001

Novel asthma gene identified as part of joint scientific collaboration

Feb. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....